NCT00920179

Brief Summary

Traditional methodological clinical and instrumental diagnostics of the lacrimal gland for the study of glandular architecture and functions are limited and include analysis of tear constituents, evaluation of apparent diffusion coefficients in magnetic resonance imaging and histopathological evaluation of lacrimal gland biopsy specimens. Confocal microscopy is a new emerging technology which is useful as a supplementary diagnostic tool for in vivo assessment of anterior-segment disorders.The use of in vivo confocal microscopy in a comparative study of the microscopic morphology of the salivary/lacrimal glands have not been reported up to date. In this study, we employ laser scanning confocal microscopy to evaluate the morphological changes of the salivary/lacrimal glands in patients with primary Sjögren's syndrome and compare the results with those of healthy control subjects.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

June 12, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 15, 2009

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Last Updated

June 15, 2009

Status Verified

June 1, 2009

Enrollment Period

3.2 years

First QC Date

June 12, 2009

Last Update Submit

June 12, 2009

Conditions

Keywords

dry eye, in vivo confocal microscopy, inflammation, acinar unit density, lacrimal gland

Outcome Measures

Primary Outcomes (1)

  • Inflammatory cell density

    1.5 years

Study Arms (2)

Dry eye group

Dry eye patients with Primary Sjogren's syndrome

Controls

Healthy subjects without dry eyes

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with primary SS and healthy controls

You may qualify if:

  • The Sjögren's syndrome diagnosis was made according to the revised American-European consensus criteria.
  • Briefly, the patients had to have ocular and oral symptoms of dryness,
  • clinically diagnosed dry eye and dry mouth disease,
  • serum rheumatoid factor and antinuclear antibody levels ≥1:160,
  • positive serology for anti SS-A or anti SS-B antibodies,
  • labial salivary gland inflammatory infiltration focus score ≥2 and consents for lacrimal gland biopsy to be included into this study.

You may not qualify if:

  • Patients with any history of ocular surgery including punctal occlusion,
  • other ocular or systemic disease
  • or a history of topical/ systemic drug use or contact lens wear or
  • other systemic disorders that would cause dry eyes or that would alter the ocular surface.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Keio University School of Medicine

Tokyo, 1608582, Japan

Location

MeSH Terms

Conditions

Dry Eye SyndromesInflammation

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Kazuo Tsubota, Professor

    Keio University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 12, 2009

First Posted

June 15, 2009

Study Start

October 1, 2007

Primary Completion

December 1, 2010

Last Updated

June 15, 2009

Record last verified: 2009-06

Locations